Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor for Patients with Chronic Myeloid Leukemia | Synapse

⌘+K

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaOriginal Research · 2016 · 480 citations
2Impact of Treatment End Point Definitions on Perceived Differences in Long-Term Outcome With Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid LeukemiaOriginal Research · 2011 · 51 citations
3EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experienceRetrospective Study · 2012 · 63 citations
4Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinantsRCT · 2017 · 341 citations
5The BCR‐ABL1 transcript type influences response and outcome in P hiladelphia chromosome‐positive chronic myeloid leukemia patients treated frontline with imatinibPrognostic Study · 2017 · 94 citations

More from Cancer Management and Research

More from Wenzhou Medical University